RAINEY WILLIAMS: Open Payments
NPI 1144610031 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 32 payments from 14 companies in 2025. Trend: 2023 $480 · 2024 $669 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| PFIZER INC. | 4 | $73 |
| ABBVIE INC. | 3 | $72 |
| Lilly USA, LLC | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Seqirus USA Inc | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| SANOFI PASTEUR INC. | 1 | $28 |
Products named: CREON, XIFAXAN, Ozempic, Fluad, Auvelity, ELIQUIS, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
